The Finnish Faecal Microbiota Transplantation Study (FINFMT)
NCT ID: NCT03732131
Last Updated: 2020-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2018-10-18
2029-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis
NCT03378921
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04759001
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NCT06156956
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
NCT03350178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving FMT for rCDI or any other madical condition
* written consent
* Not included in other FMT trials
Exclusion Criteria
* \< 18 years age
* Included in other FMT-trial
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Helsinki
OTHER
Helsinki University Central Hospital
OTHER
Turku University Hospital
OTHER_GOV
Tampere University Hospital
OTHER
Oulu University Hospital
OTHER
Kuopio University Hospital
OTHER
South Karelia, Social and Health Care District
OTHER
North Karelia Central Hospital
OTHER
Keski-Pohjanmaa Central Hospital
UNKNOWN
Seinajoki Central Hospital
OTHER
Jyväskylä Central Hospital
OTHER
Kanta-Häme Central Hospital
OTHER_GOV
Mikkeli Central Hospital
OTHER
Vaasa Central Hospital, Vaasa, Finland
OTHER
Lapland Central Hospital
UNKNOWN
Satakunta Central Hospital
OTHER
Kymenlaakso Social and Health Services
UNKNOWN
Kainuu Social and Health Care Joint Authority
OTHER
Joint Authority for Päijät-Häme Social and Health Care
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Perttu Arkkila, PhD
Role: STUDY_DIRECTOR
Head of Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joint Authority for Päijät-Häme Social and Health Care
Lahti, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUS/3198/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.